A NZ Herald article.
New Zealand may not be at the front of the queue for the data needed before the Pfizer vaccine can be approved for 12- to 15-year-olds, the Ministry of Health says.
The vaccine is currently Medsafe-approved for those aged 16 and over, but yesterday Pfizer and BioNTech released the results of their phase three clinical trial that showed 100 per cent efficacy those aged 12 to 15.
Medsafe expected to be provided the data on the trial in due course, a spokesperson for the Ministry of Health said, though New Zealand wasn’t expected to be high on the priority list.
To read more, click here.